Clinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer

about

Clinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer

Item

http://www.wikidata.org/entity/Q36972377

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Clinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer

@en

type

Item

label

Clinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer

@en

prefLabel

Clinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer

@en

P1476

Clinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer

@en

P2093

Ashley Eggert

http://www.w3.org/2001/XMLSchema#string

Neelu Puri

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting angiogenesis in squamous non-small cell lung cancer

Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies

The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non-Small Cell Lung Cancer

EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors.

Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer.

Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers.

Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer.

Two novel ALK mutations mediate acquired resistance to the next-generation ALK inhibitor alectinib

Identification of a novel HIP1-ALK fusion variant in Non-Small-Cell Lung Cancer (NSCLC) and discovery of ALK I1171 (I1171N/S) mutations in two ALK-rearranged NSCLC patients with resistance to Alectinib.

Activation of anaplastic lymphoma kinase receptor tyrosine kinase induces neuronal differentiation through the mitogen-activated protein kinase pathway

P31

scholarly article

P356

10.21767/2254-6081.100030

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gagan Chhabra

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27280107

http://www.w3.org/2001/XMLSchema#string

P932

4894332

http://www.w3.org/2001/XMLSchema#string